15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25 Although inflammation is a powerful driver of tumor growth, 26 it is the aim of this review to focus on the connection between insulin/IGF-1 signaling and cancer, and discuss possibilities to modulate these interactions through DR and pharmaceutical interventions to improve cancer outcomes
PubMed Coskun, T., Urva, S., Roell, W.C., Qu, H., Loghin, C., Moyers, J.S., OFarrell, L.S., Briere, D.A., Sloop, K.W., Thomas, M.K., Pirro, V., Wainscott, D.B., Willard, F.S., Abernathy, M., Morford, L., Du, Y., Benson, C., Gimeno, R.E., Haupt, A., & Milicevic, Z
Results vary based on the individual, treatment plan, and lifestyle habits
Epstein MA, Achong BG, Barr YM